Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A15449 | Pages: NA | Charts: NA | Tables: NA |
Capillary blood collection is a procedure to collect blood in children and infants. It is painless, simple, and requires less amount of blood when compared to other sampling procedures. Capillary blood collection is often done for disease diagnosis with blood as the patient's sample. On the other hand, venous blood collection is the procedure often done in routine laboratory tests. In venous blood collection, the blood is obtained from the patient by directly puncturing a vein located in the antecubital area of the back of the hand or the arm. The major venous blood collection devices include vacutainer systems and tubes. Capillary blood collection devices include blood collection tubes, strips, and micro sampler devices.
COVID-19 Impact AnalysiS
COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing a shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness significant growth in the future, owing to the demand for vaccines and treatment drugs for COVID-19.
With COVID-19, the supply chain of the material required to manufacture capillary and venous blood collection devices has been disrupted in many countries. In addition, the market growth of capillary and venous blood collection devices is declining, as the manufacturers of these devices have slowed down their production due to the pandemic. Therefore, COVID 19 is expected to have a significant impact on the capillary and venous blood collection devices market.
Top Impacting Factors
Key Market Trends
In 2017, VacutteEspana and Vacuette Portula were acquired by Greiner Bio-One International GmbH. This acquisition was done to strengthen the distribution and commercial network of Greiner Bio-One International’s blood collection products.
The hospital segment holds the major share of the capillary and venous blood collection devices market, owing to increasing number of diagnostic testing and surgical procedures done there. Blood work is often done before any major surgery.
North America dominates the capillary and venous blood collection devices market. This can be attributed to the region's increasing diabetic population who gets multiple blood tests done throughout the year.
Asia-Pacific is expected to show lucrative growth during the forecast period, owing to rise in the number of surgical procedures done in this region, as these procedures create a demand for blood sampling, which requires capillary and venous blood collection devices.
Key Benefits of the Report
Questions Answered in the Capillary and Venous Blood Collection Devices Market Report
Key Market Segments
Key Market Players